Rosty Raykov - Oct 8, 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Rosty Raykov
Stock symbol
FENC
Transactions as of
Oct 8, 2025
Transactions value $
$0
Form type
4
Date filed
10/8/2025, 05:08 PM
Previous filing
Oct 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Raykov Rosty Director C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK /s/ Rosty Raykov 2025-10-08 0001468316

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $11.3K +4.61K +5.59% $2.45 87.1K Oct 8, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise -$11.3K -4.61K -0.28% $2.45 1.63M Oct 8, 2025 options 4.61K $2.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.